Skip to main content
Year archive

PYC THERAPEUTICS LIMITED — 2023 filings

All 72 regulatory filings released by PYC THERAPEUTICS LIMITED (PYC) in 2023, sourced directly from the official regulator.

72 Filings
2023 Period
2023 filings (72)
Filing Released Lang
RP11 Clinical Trial Progressing To High Dose Cohort 3 pages 278.1KB
Regulatory Filings
2023-12-17 English
Notification of cessation of securities - PYC 4 pages 23.9KB
Regulatory Filings
2023-11-30 English
Response to Price Query 5 pages 331.1KB
Regulatory Filings
2023-11-29 English
2023 AGM Chairman's Address and CEO Presentation 9 pages 1.4MB
Regulatory Filings
2023-11-23 English
Results of Annual General Meeting 2 pages 215.6KB
Regulatory Filings
2023-11-23 English
Annual General Meeting - Conference Call 2 pages 201.8KB
Regulatory Filings
2023-11-20 English
Polycystic Kidney Disease Program Presentation 21 pages 2.7MB
Regulatory Filings
2023-11-16 English
Supplementary Information 7 pages 566.4KB
Regulatory Filings
2023-11-15 English
New Drug For Major Kidney Disease Effective In Human Models 5 pages 548.6KB
Regulatory Filings
2023-11-12 English
PYC and FDA Align On Clinical Trial Pathway in ADOA 3 pages 248.6KB
Regulatory Filings
2023-11-05 English
RP11 Clinical Trial Dosing Completed In Patient Cohort 2 3 pages 284.8KB
Regulatory Filings
2023-11-02 English
Wilsons Drug & Device Conference Presentation 13 pages 2.5MB
Regulatory Filings
2023-10-25 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 479.6KB
Regulatory Filings
2023-10-24 English
Annual Report to shareholders 92 pages 4.1MB
Regulatory Filings
2023-10-23 English
2023 Corporate Governance Statement and Appendix 4G 37 pages 969.9KB
Regulatory Filings
2023-10-23 English
Notice of Annual General Meeting/Proxy Form 21 pages 985.4KB
Regulatory Filings
2023-10-23 English
PYC Presenting on PYC-001 Program at OTS 2023 Meeting 2 pages 239.5KB
Regulatory Filings
2023-10-19 English
Notification regarding unquoted securities - PYC 7 pages 32.0KB
Regulatory Filings
2023-10-15 English
Investor Presentation ADOA Program 17 pages 1.6MB
Regulatory Filings
2023-10-04 English
PYC-001 Effective In Both NHPs and Patient-Derived Models 6 pages 512.9KB
Regulatory Filings
2023-10-03 English
Q3 Investor Call Presentation 9 pages 647.0KB
Regulatory Filings
2023-09-26 English
Safety Review Committee Approves Dose Escalation 3 pages 264.2KB
Regulatory Filings
2023-09-21 English
Q3 Investor Call 27 September 2023 2 pages 221.8KB
Regulatory Filings
2023-09-18 English
E&P Healthcare Conference Presentation 14 pages 2.1MB
Regulatory Filings
2023-09-11 English
Appendix 4E and Audited Financial Statements 66 pages 3.7MB
Regulatory Filings
2023-08-30 English
Notification of cessation of securities - PYC 4 pages 24.0KB
Regulatory Filings
2023-08-20 English
RP11 Clinical Trial Dosing Completed In Patient Cohort 1 2 pages 239.0KB
Regulatory Filings
2023-08-16 English
PYC Increases Ownership of VP-001 Program 2 pages 244.4KB
Regulatory Filings
2023-08-09 English
PYC Receives FDA Fast Track Designation 3 pages 249.0KB
Regulatory Filings
2023-08-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 467.5KB
Regulatory Filings
2023-07-25 English
Successful Toxicology Results Pave Way for Phase 2 Trial 4 pages 303.9KB
Regulatory Filings
2023-07-17 English
Change in substantial holding 3 pages 119.4KB
Regulatory Filings
2023-07-17 English
Application for quotation of securities - PYC 6 pages 27.8KB
Regulatory Filings
2023-07-13 English
Cleansing Notice Under Section 708AA 2 pages 220.8KB
Regulatory Filings
2023-07-13 English
Change of Director's Interest Notice 2 pages 241.3KB
Regulatory Filings
2023-07-13 English
Change of Director's Interest Notice 2 pages 234.8KB
Regulatory Filings
2023-07-13 English
Change in substantial holding 2 pages 152.9KB
Regulatory Filings
2023-07-13 English
Q3 Investor Call Advance Notice 3 pages 265.5KB
Regulatory Filings
2023-07-09 English
Results of Meeting 2 pages 236.3KB
Regulatory Filings
2023-07-04 English
Change of Director's Interest Notice 2 pages 260.6KB
Regulatory Filings
2023-07-03 English
FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL 3 pages 273.3KB
Regulatory Filings
2023-06-29 English
Change of Director's Interest Notice 2 pages 257.2KB
Regulatory Filings
2023-06-27 English
PYC Investor Update Presentation 19 pages 1.6MB
Regulatory Filings
2023-06-15 English
Q2 Investor Call 16 June 2023 2 pages 247.0KB
Regulatory Filings
2023-06-07 English
Phelan-McDermid Syndrome & CNS platform presentation 15 pages 937.9KB
Regulatory Filings
2023-06-05 English
Notice of General Meeting/Proxy Form 19 pages 994.3KB
Regulatory Filings
2023-06-01 English
Appointment of Joint Company Secretary 1 page 188.5
Regulatory Filings
2023-05-31 English
Ceasing to be a substantial holder 2 pages 291.3KB
Regulatory Filings
2023-05-21 English
Ceasing to be a substantial holder 1 page 100.5KB
Regulatory Filings
2023-05-21 English
Application for quotation of securities - PYC 6 pages 27.9KB
Regulatory Filings
2023-05-18 English
Cleansing Notice Under Section 708AA 2 pages 220.7KB
Regulatory Filings
2023-05-18 English
Successful Completion of $30m Placement 3 pages 264.9KB
Regulatory Filings
2023-05-10 English
Placement Supporting Document 27 pages 1.7MB
Regulatory Filings
2023-05-10 English
Proposed issue of securities - PYC 5 pages 28.2KB
Regulatory Filings
2023-05-10 English
Trading Halt 3 pages 624.6KB
Regulatory Filings
2023-05-08 English
PYC Presenting at TIDES USA 2023 2 pages 256.6KB
Regulatory Filings
2023-05-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 380.0KB
Regulatory Filings
2023-04-27 English
Commencement of First Clinical Study in RP11 3 pages 256.9KB
Regulatory Filings
2023-04-25 English
PYC BIO 2023 Presentation 31 pages 1.7MB
Regulatory Filings
2023-04-18 English
Second Drug Program Progressing to Human Trials 5 pages 349.2KB
Regulatory Filings
2023-04-02 English
Application for quotation of securities - PYC 8 pages 32.8KB
Regulatory Filings
2023-03-06 English
Cleansing Notice Under Section 708AA 2 pages 253.7KB
Regulatory Filings
2023-03-06 English
FDA Clears PYC to Commence First Human Trials in RP11 2 pages 187.1KB
Regulatory Filings
2023-03-05 English
Trading Halt 3 pages 585.7KB
Regulatory Filings
2023-03-01 English
Half Yearly Report and Accounts 21 pages 1.1MB
Regulatory Filings
2023-02-27 English
PYC Investor Update Presentation 21 pages 788.7KB
Regulatory Filings
2023-02-16 English
Notification regarding unquoted securities - PYC 7 pages 30.4KB
Regulatory Filings
2023-02-14 English
Issue of Options 2 pages 247.3KB
Regulatory Filings
2023-02-14 English
Q1 Investor Call 17 February 2023 2 pages 194.2KB
Regulatory Filings
2023-02-09 English
PYC Corporate Presentation - February 2023 37 pages 2.8MB
Regulatory Filings
2023-02-02 English
VP-001 IND Lodgement 2 pages 165.3KB
Regulatory Filings
2023-02-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 230.6KB
Regulatory Filings
2023-01-19 English